We are live on
!
Find out more
TEC
Tiger Eye Capital Portfolio holdings
AUM
$113M
1-Year Est. Return
11.44%
This Fund
S&P 500
This Quarter
Est. Return
+9.47%
1 Year Est. Return
-11.44%
3 Year Est. Return
+116.39%
5 Year Est. Return
+328.27%
10 Year Est. Return
–
AUM
$480M
AUM Growth
+$68.6M
(+17%)
Cap. Flow
+$33.5M
Cap. Flow
% of AUM
6.98%
Top 10 Holdings %
Top 10 Hldgs %
68.76%
Holding
52
New
8
Increased
12
Reduced
11
Closed
6
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Upland Software
UPLD
|
+$18.8M |
| 2 |
GLIBA
GCI Liberty, Inc. Class A Common Stock (DE)
GLIBA
|
+$15.7M |
| 3 |
Waste Management
WM
|
+$12.3M |
| 4 |
Amazon
AMZN
|
+$10.3M |
| 5 |
NVRO
NEVRO CORP.
NVRO
|
+$10M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Thermo Fisher Scientific
TMO
|
+$17.6M |
| 2 |
Mastercard
MA
|
+$17M |
| 3 |
Elevance Health
ELV
|
+$13.4M |
| 4 |
AABA
Altaba Inc
AABA
|
+$11.1M |
| 5 |
Netflix
NFLX
|
+$8.4M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 35.68% |
| 2 | Communication Services | 35.62% |
| 3 | Healthcare | 8.12% |
| 4 | Consumer Discretionary | 7.37% |
| 5 | Financials | 7.07% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
EVOP
26
DELISTED
EVO Payments, Inc. Class A Common Stock
EVOP
| $2.91M | 0.61% |
92,343
+73,611
| +393% | +$2.15M |
|
|
PLAN
27
DELISTED
Anaplan, Inc.
PLAN
| $2.35M | 0.49% |
46,598
-114,810
| -71% | -$4.75M |
|
28
Ferrari
RACE
$76.7B
| $1.13M | 0.24% |
7,021
| – | – |
|
29
Twilio
TWLO
$34.6B
| $1.13M | 0.23% |
+8,275
| New | +$1.1M |
|
30
JPMorgan Chase
JPM
$935B
| $1.1M | 0.23% |
9,806
| – | – |
|
31
Meta Platforms (Facebook)
META
$1.4T
| $1.09M | 0.23% |
5,635
| – | – |
|
32
Adaptive Biotechnologies
ADPT
$4.15B
| $773K | 0.16% |
+16,000
| New | +$709K |
|
33
UnitedHealth
UNH
$350B
| $701K | 0.15% |
2,871
-15,944
| -85% | -$3.83M |
|
34
XPO
XPO
$23.2B
| $644K | 0.13% |
32,219
| – | – |
|
35
Vail Resorts
MTN
$5.45B
| $638K | 0.13% |
2,858
| – | – |
|
|
TMX
36
DELISTED
Terminix Global Holdings, Inc.
TMX
| $530K | 0.11% |
10,170
| – | – |
|
37
D.R. Horton
DHI
$41.5B
| $475K | 0.1% |
11,024
| – | – |
|
38
Cable One
CABO
$129M
| $415K | 0.09% |
354
| – | – |
|
39
Forum Energy Technologies
FET
$871M
| $378K | 0.08% |
5,529
+300
| +6% | +$28.6K |
|
|
40
Thermo Fisher Scientific
TMO
$233B
| $358K | 0.07% |
1,220
-63,721
| -98% | -$17.6M |
|
41
Alphabet (Google) Class C
GOOG
$4.18T
| $340K | 0.07% |
6,300
| – | – |
|
42
Charter Communications
CHTR
$17.9B
| $277K | 0.06% |
700
| – | – |
|
|
XYZ
43
Block Inc
XYZ
$49.4B
| $248K | 0.05% |
3,418
| – | – |
|
44
T-Mobile US
TMUS
$196B
| $241K | 0.05% |
3,253
| – | – |
|
45
Frontdoor
FTDR
$5.69B
| $221K | 0.05% |
+5,085
| New | +$195K |
|
46
Liberty Media Series A
FWONA
$24.2B
| $211K | 0.04% |
6,153
| – | – |
|
|
47
Elevance Health
ELV
$86.9B
| – | – |
-46,719
| Closed | -$13.4M |
|
48
Etsy
ETSY
$7.44B
| – | – |
-14,820
| Closed | -$996K |
|
49
Intuitive Surgical
ISRG
$134B
| – | – |
-4,470
| Closed | -$850K |
|
|
50
Mastercard
MA
$509B
| – | – |
-72,002
| Closed | -$17M |
|
Similar funds
SCA
KWM
NF
PCG
BA
EL
CFN
BRWM
Tiger Eye Capital's Q2 2019 Portfolio in Review
As of Q2 2019, Tiger Eye Capital held 52 positions worth $480M, up 17% from $412M the previous quarter. Its ten largest holdings account for 69% of the portfolio.
Tiger Eye Capital deployed $33.5M of net new capital in Q2 2019, opening 8 new positions and adding to 12 existing holdings. Its largest new stake was Upland Software: 41,068 shares worth $18.7M.
By sector, the portfolio is most concentrated in Technology at 36% of assets, up from 31% a quarter earlier, followed by Communication Services and Healthcare.
On the sell side, the largest reduction was Thermo Fisher Scientific, an estimated $17.6M trimmed.
- Tiger Eye Capital's largest Q2 2019 buy was Upland Software: 41,068 shares worth $18.7M.
- Tiger Eye Capital added most to GCI Liberty, Inc. Class A Common Stock (DE) in Q2 2019, an estimated $15.7M increase.
- Tiger Eye Capital's biggest Q2 2019 reduction was Thermo Fisher Scientific, cutting an estimated $17.6M.
- Tiger Eye Capital fully exited Mastercard in Q2 2019, selling an estimated $17M.
- Tiger Eye Capital's ten largest holdings make up 69% of its $480M portfolio in Q2 2019.
- Tiger Eye Capital opened 8 new positions and closed 6 in Q2 2019.
- Tiger Eye Capital's portfolio value rose 17% quarter-over-quarter to $480M.
Based on Tiger Eye Capital's 13F filing for Q2 2019, filed 14 Aug 2019.